USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name: DYNAMIS THERAPEUTICS, INC.
City: JENKINTOWN
State: PA
Zip+4: 19046
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
Website URL: N/A
Phone: N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $257,579.00 1

Award List:

Discovery of FN3K Inhibitors to Treat Diabetic Complications

Award Year / Program / Phase: 2010 / SBIR / Phase I
Agency: HHS
Principal Investigator: Alice Marcy
Award Amount: $257,579.00
Abstract:
DESCRIPTION (provided by applicant): The glucose metabolite 3-deoxyglucosone (3DG) is a highly reactive, dicarbonyl, proinflammatory molecule that induces oxidative stress and is a precursor to the formation of advanced glycation end products (AGEs), which are believed to be important in mechanisms… More